Fe/sub 2/Cl/sub 3/
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... and Fe) was detected by inductively coupled plasma (ICP) mass spectrometry (MS; Nexion 300D; PerkinElmer ...caspase 3, Bcl2, Bax, p50, p53, Nrf2, Akt, and GAPDH were obtained from Cell Signaling Technology ...
15
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... All univariate statistical tests were two-sided, and sig- nificance was set at P,0.05. Multivariate statistical analysis can take internal relationships and mutual influence among variables into account; therefore, the ...
16
<p>Green Synthesis of Zeolite/Fe<sub>2</sub>O<sub>3</sub> Nanocomposites: Toxicity & Cell Proliferation Assays and Application as a Smart Iron Nanofertilizer</p>
... were cytotoxic towards renal carcinoma Caki-2 cells without imposing apoptosis or growth inhibition in normal kidney epithelial cells. 47 In the work of Shanmugasundaram et al, bio-synthesized superparamagnetic ...
16
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... of Fe 3 O 4 @Au composite ...the Fe 3 O 4 @Au composite MNPs after intraperitoneal administration in mice was ...1, 2, 3, and 4 weeks after liver injection and no behavioral ...
15
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... The procedure followed to prepare the proposed immunosen- sor is schematized in Figure 1C. The GCE was polished with 0.3 µ m and 0.05 µ m alumina, followed by successive sonica- tion in distilled water and ethanol for 5 ...
11
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... -Fe 2 O 3 . Using TEM characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical shape with mean diameter of 98 ± ...
11
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... of Fe 3 O 4 ...experimental Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...the Fe 3 O 4 -MNPs/DNR was ...experimental Fe 3 O 4 -MNPs/ DNR groups were ...
6
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... different pH levels which are similar to the pH of the stomach and the pH of the blood. Generally, the pH of the stomach varies from 1–2 to 4–5. After eating, the stomach releases proteases and hydrochloric acid ...
12
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... the Fe 3 O 4 nanoparticles were biocompatible and suitable for biomedi- cal ...The Fe 3 O 4 was treated with low temperature intermittent sterilization, and RPMI 1640 culture medium containing ...
10
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... of Fe 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...standard Fe 3 O 4 pattern published by ...Dex/Fe 3 O 4 and Bis/Dex/ ...
12
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... (Fe 3 O 4 ) nanoparticles (NPs) have been extensively exploited as ferrofluids in various industrial ...therapeutics. Fe 3 O 4 NPs usually present super paramagnetic properties and by altering ...
10
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... for Fe 3 O 4 MNPs and changes in their tissue concentrations in the liver and ...of Fe 3 O 4 MNPs were ingested by mononuclear macrophages in the liver or spleen after being absorbed into the ...
6
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... of Fe 3 O 4 (MNPs-Fe 3 O 4 ...MNPs-Fe 3 O 4 dramati- cally enhanced GA-induced cytotoxicity and apoptosis in K562 ...MNPs-Fe 3 O 4 were observed under an optical ...
9
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... MNP-Fe 3 O 4 with different chemo- therapeutics may provide new clinical options in the treatment of ...MNP-Fe 3 O 4 with other compounds, eg, adriamycin, daunorubicin, and dexamethasone, all ...
6
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... daunorubicin, Fe 3 O 4 -MNP, and Fe 3 O 4 -MNP coloaded with daunorubicin and 5-bromotetrandrine (Fe 3 O 4 -MNP-DNR-5-BrTet), with hyperthermia in an alternating magnetic ...
9
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... MNP-Fe 3 O 4 adaptations in the face of elevated sympathetic nervous system ...MNPs-Fe 3 O 4 has no significant influence on the expression profile of KCNQ 1 in rested or in exercised mice ...
8
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... (Fe 3 O 4 ) nanoparticles with appropriate surface modification, which have been widely used experimentally for numerous in vivo applications, such as magnetic resonance imaging, tissue repair, immunoassay, ...
6
Gd<sub>2</sub>O<sub>3</sub> nanoparticles in hematopoietic cells for MRI contrast enhancement
... (Gd 2 O 3 ) nanoparticles generate higher relaxivity than currently available Gd chelates: In addition, the Gd 2 O 3 nanoparticles have promising properties for MRI cell ...Gd 2 O ...
8
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... Several management options are available when prostate cancer is diagnosed at an early stage, including watchful waiting, surgery, cryosurgery, radiation therapy, and hormonal therapy. For advanced prostate cancers, ...
10
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... the Fe 3 O 4 -PLGA-PEG nanoparticles was also pH-dependent and enhanced at pH ...the Fe 3 O 4 -PLGA-PEG nanoparticles by a diffusion mechanism in ...
16